Health Catalyst, Inc (HCAT) Dividend History

Company News

• Medical Device Security Market to Hit USD 15.02 Billion by 2032, Driven by Increasing Healthcare Cyber-attacks | Report by Coherent Market Insights

  The global medical device security market is projected to grow from USD 8.32 Bn in 2025 to USD 15.02 Bn by 2032, driven by increasing healthcare cyber-attacks and the rise of IoT-enabled medical devices. The market faces challenges from high implementation costs but benefits from growing cybersecurity needs.

  GlobeNewswire Inc.

  Featured Companies: MDT
• Time to Play 5 Top-Ranked Stocks With Rising P/E?

  Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

  Zacks Investment Research

  Featured Companies: AMC APDN XGN YOU
• Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

  Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the current average surpasses the previous average price target of $13.33. Understanding Analyst Ratings: A Comprehensive Breakdown A clear picture of Health Catalyst's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jessica Tassan Piper Sandler Lowers Overweight $14.00 $15.00 Richard Close Canaccord Genuity Maintains Buy $11.00 $11.00 Stan Berenshteyn Wells Fargo Lowers Overweight $13.00 $14.00 Sarah James Cantor Fitzgerald Maintains Overweight $16.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Health Catalyst. This information provides a snapshot of how analysts ...Full story available on Benzinga.com

  Benzinga
• Why Health Catalyst Stock Rallied Wednesday Morning

  The data analytics specialist delivered results that weren't as bad as investors had feared.

  The Motley Fool